Transplantation and islet topics

Diabetes Care

Volumn 28, Issue 1, 2005, Pages 213-219

  Bloomgarden, Zachary T ^a,b  

^a Mount Sinai School of Medicine ^*

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALEMTUZUMAB; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; COTRIMOXAZOLE; CYCLOSPORIN; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GANCICLOVIR; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INTERFERON; INTERLEUKIN 2 RECEPTOR ANTIBODY; METFORMIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; OKT 3; PHOSPHATIDYLINOSITOL KINASE; PIOGLITAZONE; RAPAMYCIN; ROSIGLITAZONE; STATIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

CELL REGENERATION; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; DYSLIPIDEMIA; EDEMA; GASTROINTESTINAL SYMPTOM; GLUCOSE TOLERANCE; GRAFT REJECTION; HEMODIALYSIS; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIFESTYLE; LIVER TRANSPLANTATION; LUNG CONGESTION; MOUTH ULCER; NEUROLOGIC DISEASE; OSTEOPOROSIS; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN DISEASE; SURVIVAL;

ANIMALS; DIABETES MELLITUS; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD; PANCREAS TRANSPLANTATION; REGENERATION; TRANSPLANTATION;

EID: 11844282702     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.1.213     Document Type: Review

References (30)

1. Davidson JA, Wilkinson A, the International Expert Panel on New-Onset Diabetes after Transplantation: New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist's view. Diabetes Care 27: 805-812, 2004
2. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM: Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int. 59:732-737, 2001
3. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ: Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3:178-185, 2003
4. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM: Patient survival after renal transplantation. IV. Impact of post-transplant diabetes. Kidney Int 62: 1440-1446, 2002
5. Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, Haider S, Woodworth TG, Brennan DC: Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allogratt recipients. Am J Transplant 3:590-598, 2003
6. Sumrani NB, Delaney V, Ding ZK, Davis R, Daskalakis P, Friedman EA, Butt KM, Hong JH: Diabetes mellitus after renal transplantation in the cyclosporine era - an analysis of risk factors. Transplantation 51:343-347, 1991
7. Weir MR, Fink JC: Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 34:1-13, 1999
8. Lambillotte C, Gilon P, Henquin JC: Direct glucocorticoid inhibition of insulin secretion: an in vitro study of dexamethasone effects in mouse islets. J Clin Invest 99:414-423, 1997
9. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC: Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 25:583-592, 2002
10. Uchizono Y, Iwase M, Nakamura U, Sasaki N, Goto D, Iida M: Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling. Endocrinology 145:2264-2272, 2004
11. Drachenberg CB, Klassen DK, Weir MR, Wiland A, Fink JC, Bartlett ST, Cangro CB, Blahut S, Papadimitriou JC: Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 68:396-402, 1999
12. Berg CE, Lavan BE, Rondinone CM: Rapamycin partially prevents insulin resistance induced by chronic insulin treatment. Biochem Biophys Res Commun 293:1021-1027, 2002
13. Zheng XX, Sanchez-Fueyo A, Sho M, Domenig C, Sayegh MH, Strom TB: Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19: 503-514, 2003
14. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL: Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133:592-599, 2000
15. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC: Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 13:1374-1380, 2002
16. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N: Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 38:1384-1392, 2003
17. Baid S, Cosimi AB, Farrell ML, Schoenfeld DA, Feng S, Chung RT, Tolkoff-Rubin N, Pascual M: Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 72:1066-1072, 2001
18. Kamar N, Toupance O, Buchler M, Sandres-Saune K, Izopet J, Durand D, Rostaing L: Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol 14:2092-2098, 2003
19. Baldwin D Jr, Duffin KE: Rosiglitazone treatment of diabetes mellitus after solid organ transplantation. Transplantation 77: 1009-1014, 2004
20. Nishimura R, LaPorte RE, Dorman JS, Tajima N, Becker D, Orchard TJ: Mortality trends in type 1 diabetes: the Allegheny County (Pennsylvania) Registry 1965-1999. Diabetes Care 24:823-827, 2001
21. Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM: Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 290:2817-2823, 2003
22. Jukema JW, Smets YF, van der Pijl JW, Zwinderman AH, Vliegen HW, Ringers J, Reiber JH, Lemkes HH, van der Wall EE, de Fijter JW: Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 25:906-911, 2002
23. La Rocca E, Fiorina P, di Carlo V, Astorri E, Rossetti C, Lucignani G, Fazio F, Giudici D, Cristallo M, Bianchi G, Pozza G, Secchi A: Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 60:1964-1971. 2001
24. Matas AJ, Payne WD, Sutherland DE, Humar A, Gruessner RW, Kandaswamy R, Dunn DL, Gillingham KJ, Najarian JS: 2,500 living donor kidney transplants: a single-center experience. Ann Surg 234: 149-164, 2001
25. Kiberd BA, Larson T: Estimating the benefits of solitary pancreas transplantation in nonuremic patients with type 1 diabetes mellitus: a theoretical analysis. Transplantation 70:1121-1127, 2000
26. Sasaki TM, Gray RS, Ratner RE, Currier C, Aquino A, Barhyte DY, Light JA: Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels: Transplantation 65: 1510-1512, 1998
27. Ryu S, Kodama S, Ryu K, Schoenfeld DA, Faustman DL: Reversal of established autoimmune diabetes by restoration of endogenous β cell function. J Clin Invest 108:63-72, 2001
28. Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, Thyssen S, Gray DA, Bhatia M: Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21:763-770, 2003
29. Mathews V, Hanson PT, Ford E, Fujita J, Polonsky KS, Graubert TA: Recruitment of bone marrow-derived endothelial cells to sites of pancreatic β-cell injury. Diabetes 53:91-98, 2004
30. Dor Y, Brown J, Martinez OI, Melton DA: Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46, 2004